We already have the situation that normal vaccines are sold for prices to make a profit to developed countries and then sold for lesser prices to organizations that give out the vaccines to the the of the world.
That’s the established model that works for giving everybody access and the involved companies a way to pay for the vaccine development.
It doesn’t get them to pay for a lot of vaccine factories and as a result we don’t have enough vaccine factories at the moment but I would still call the model for-profit.
We already have the situation that normal vaccines are sold for prices to make a profit to developed countries and then sold for lesser prices to organizations that give out the vaccines to the the of the world.
That’s the established model that works for giving everybody access and the involved companies a way to pay for the vaccine development.
It doesn’t get them to pay for a lot of vaccine factories and as a result we don’t have enough vaccine factories at the moment but I would still call the model for-profit.